Bruker Corp (NASDAQ: BRKR) has seen a decline in its stock price by -3.74 in relation to its previous close of 39.08. However, the company has experienced a -7.48% decline in its stock price over the last five trading sessions. zacks.com reported 2025-06-10 that BRKR strengthens its MS-based metabolomics platform with the biocrates deal, boosting investor sentiment.
Is It Worth Investing in Bruker Corp (NASDAQ: BRKR) Right Now?
Bruker Corp (NASDAQ: BRKR) has a price-to-earnings ratio of 71.64x that is above its average ratio. Additionally, the 36-month beta value for BRKR is 1.16. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 2 rating it as “overweight,” 8 rating it as “hold,” and 0 rating it as “sell.”
The public float for BRKR is 102.99M and currently, short sellers hold a 9.03% ratio of that float. The average trading volume of BRKR on June 18, 2025 was 2.36M shares.
BRKR’s Market Performance
The stock of Bruker Corp (BRKR) has seen a -7.48% decrease in the past week, with a 0.24% rise in the past month, and a -20.20% fall in the past quarter. The volatility ratio for the week is 3.03%, and the volatility levels for the past 30 days are at 2.50% for BRKR. The simple moving average for the last 20 days is -0.60% for BRKR stock, with a simple moving average of -27.92% for the last 200 days.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with Citigroup repeating the rating for BRKR by listing it as a “Neutral.” The predicted price for BRKR in the upcoming period, according to Citigroup is $40 based on the research report published on May 22, 2025 of the current year 2025.
Guggenheim, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $72. The rating they have provided for BRKR stocks is “Buy” according to the report published on December 19th, 2024.
UBS gave a rating of “Neutral” to BRKR, setting the target price at $66 in the report published on December 10th of the previous year.
BRKR Trading at -1.91% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.42% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from LAUKIEN FRANK H, who purchase 2,608 shares at the price of $38.36 back on Jun 06 ’25. After this action, LAUKIEN FRANK H now owns 38,462,171 shares of Bruker Corp, valued at $100,043 using the latest closing price.
Bures Thomas, the Chief Accounting Officer of Bruker Corp, purchase 500 shares at $47.40 during a trade that took place back on Mar 10 ’25, which means that Bures Thomas is holding 3,472 shares at $23,698 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.49 for the gross margin
The net margin for Bruker Corp stands at 0.02. The total capital return value is set at 0.05. Equity return is now at value 4.92, with 1.52 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.54 points at debt to capital in total, while cash flow to debt ratio is standing at 0.14. The debt to equity ratio resting at 1.16. The interest coverage ratio of the stock is 4.39.
Currently, EBITDA for the company is 438.6 million with net debt to EBITDA at 4.21. When we switch over and look at the enterprise to sales, we see a ratio of 2.21. The receivables turnover for the company is 4.92for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.57.
Conclusion
In conclusion, Bruker Corp (BRKR) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
